Buying Time on the 2026 Planting Window

By Shawn Collins of the THC Group. For more insights, check out his Policy, Decoded newsletter.

What Happened: Representative Jim Baird (R-IN) and a heavyweight bipartisan group, including House Oversight Chair James Comer (R-KY), House Agriculture Ranking Member Angie Craig (D-MN), and North Carolina Speaker-turned-Congressman Tim Moore (R-NC), formally introduced HR 7010 (the Hemp Planting Predictability Act) on January 12. The bill targets the compliance cliff created by the November 2025 shutdown Appropriations Act that established an aggressive 0.4mg per-package total THC cap. By extending the implementation deadline from one year to three, HR 7010 pauses the ban until November 2028. This move responds to intense pressure from agricultural and wellness interests who argue that without immediate relief, the 2026 planting season is dead on arrival.

Why It Matters: The urgency here is driven by a collision between the biological reality of farming and a significant shift in White House policy. Farmers are finalizing planting contracts for 2026 right now. They cannot risk capital on a crop that could be reclassified as contraband before harvest. Simultaneously, President Trump’s December 18th Executive Order (EO 14370) has changed the math. That order directs the CMS to launch a Medicare pilot program for full-spectrum CBD products. If the 0.4mg cap remains, the very therapeutic oils the President wants for seniors and veterans would technically become Schedule I narcotics. This policy friction, where one federal agency is banning what another is attempting to reimburse, provides the necessary leverage for Republican leadership to revisit a law passed just months ago.

THC Group Take: HR 7010 is a critical survival maneuver for the hemp-derived beverage and wellness sectors. It attempts to sync the industry’s timeline with the new “medical-first” narrative coming from the White House. By pushing the deadline to 2028, the bill creates a roughly 34-month window for the CMS pilot to generate real clinical data. This data could eventually justify a permanent, science-based THC threshold rather than an arbitrary cap.

However, we should not assume this specific bill will become law. It is one of several competing proposals, including Senator Ron Wyden’s more comprehensive effort to build a federal regulatory framework from the ground up. The true value of HR 7010 is as an exercise in political acumen and industry maturation. It serves as a vehicle to demonstrate to a Congress, many of whom have never seen or tried a hemp beverage, that the market is real and the consumer demand is legitimate. By championing this legislation, operators are effectively demonstrating that they are not asking for a lack of oversight, but for responsible, workable rules. This is an opening bid in a winding process. The industry must use this window to prove it is ready for regular order by institutionalizing professional standards in age-gating and labeling, moving the conversation away from prohibition and toward permanent, professionalized regulation.

This article is from an external, unpaid contributor. It does not represent IgniteIt’s reporting and has not been edited for content or accuracy. 

Photo by GreenForce Staffing on Unsplash